HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

12th Edition of International Conference on Neurology and Brain Disorders

October 20-22, 2025

October 20 -22, 2025 | Orlando, Florida, USA

Basal Ganglia Diseases

Basal Ganglia Diseases

The Basal Ganglia is a group of structures located deep within the brain, which is made up of neurons that send electrical impulses to other parts of the brain to coordinate movement. These structures are important for controlling voluntary movements, such as walking, and maintaining balance and posture when standing or sitting. Basal Ganglia diseases involve damage to these structures, leading to impairments in movement, balance, and posture. The most common Basal Ganglia diseases are Parkinson’s disease, Huntington’s disease, and tardive dyskinesia. Parkinson’s disease is characterized by a lack of dopamine-containing neurons in the Substantia Nigra region of the Basal Ganglia, which causes problems with motor coordination, balance, and posture. Typical symptoms include tremor, stiffness, and a slowing of movement. Huntington’s disease is another disorder of the Basal Ganglia, caused by genetic defects that cause progressive deterioration of the brain, leading to the death of neurons and the death of the person from complete brain disintegration. Symptoms of Huntington’s disease include jerky movements, loss of coordination, and mental deterioration. Tardive dyskinesia is often caused by long-term use of antipsychotic medications and is characterized by writhing and involuntary movements. More recently, research has also suggested that other Basal Ganglia diseases, such as Tourette’s syndrome, Gilles de la Tourette Syndrome, developmental delay, and autism, may be caused by dysfunction in the Basal Ganglia. In each of these disorders, impairments in motor coordination and posture are common, as well as issues with language and communication. Treatment of Basal Ganglia diseases can vary greatly, depending on the specific disorder. For example, treatment of Parkinson’s disease often involves medications that increase dopamine levels in the brain, while Huntington’s disease is often treated with a combination of medications, physical therapy, and lifestyle modifications. Additionally, therapies such as deep brain stimulation and transcranial magnetic stimulation have also been used to help improve the symptoms of Basal Ganglia diseases. In summary, Basal Ganglia diseases involve damage to the structures in the brain responsible for controlling movement, balance, and posture.

Committee Members
Speaker at Neuroscience Conference - Ken Ware

Ken Ware

NeuroPhysics Therapy Institute and Research Centre, Australia
Speaker at Neurology and Brain Disorders - Joe Sam Robinson

Joe Sam Robinson

Mercer University, United States
Speaker at Neurology Conferences - Robert B Slocum

Robert B Slocum

University of Kentucky HealthCare, United States
INBC 2025 Speakers
Speaker at Brain Disorders Conference - Thomas J Webster

Thomas J Webster

Interstellar Therapeutics, United States
Speaker at Neuroscience Conference - Roger H Coletti

Roger H Coletti

Interventional Health, PA, United States
Speaker at Neuroscience Conference - Stephen Grossberg

Stephen Grossberg

Boston University, United States
Speaker at Brain Disorders Conference - George Diaz

George Diaz

Memorial Healthcare Systems, United States

Submit your abstract Today

Watsapp